Introducing a New Discovery in the Prevention of Hypertrophic Scars
Scars are unavoidable with all incisions but normal in most cases. However, there is always a possibility that a hypertrophic scar may occur which cannot be predicted.
In fact, the prevalence of hypertrophic scars among Caucasians is up to 63%, and even higher among non-Caucasians, while the incidence rates can be as high as 70% following surgery. The fear of scarring is actually consistently ranked as the 4th most common reason why patients don’t schedule a surgery.
V-STAT™ Advanced Scar Gel** is the only topical gel that is proven as an effective prophylaxis against hypertrophic scar formation.
What are hypertrophic scars?
Hypertrophic scars are visible and elevated scars that don’t extend beyond the original wound. They are the most common scars following an injury or surgery and occur when the skin does not follow the proper healing process. This results in an increase of collagen fibers in the affected area which makes the scar appear raised and inflamed.
V-STAT™ Advanced Scar Gel** minimizes the appearance of new scars and repairs dry skin with 0.8% Polyamine-DAB™, a polyamine that plays an important role in the healing and aging process of the skin. The role of this polyamine was discovered by a Plastic Surgeon backed by 30 years of research and 5 patents on this molecule.
Who is it for?
Prevention of hypertrophic scars following:
|Once bandage and sutures have been removed (and there is no infection) apply sufficient quantity over the area twice daily until the scar appears flat and white without redness|
|MEDICAL||Healing of dermatological compromised skin such as dry, chapped skin on the hands, feet and lips||Once skin has completely healed (and there is no infection) apply sufficient quantity over the area twice a day as needed|
|COSMETIC||Improved healing following ablative and non-ablative procedures (lasers, chemical peels)||
Once the skin has healed (re-epithelialization approximately 72 hours)
A randomized prospective double-blind clinical trial was conducted on 56 patients using 0.8% Polyamine-DAB™ on scars following breast reduction surgery.
- Patients testimonials revealed a 99% concordance with the treated side being subjectively better
- Wound healing satisfactory in all patients studied
- 30 patient interim analysis revealed a significant difference in duredness
- Prophylaxis was an important conclusion
- A significant number of patients reported objective reduction in their scar on the treated side compared to the control scar during one year minimum follow-up